Back
Chugai Pharmaceutical Vs. Nxera Pharma Industry Stock Comparison
Sell
48
CHGCY
Chugai Pharmaceutical
Last Price:
$21.34
Seasonality Move:
5.82%
Sell
18
SOLTF
Nxera Pharma
Last Price:
$6.16
Seasonality Move:
16.5%
Sell
48
Chugai Pharmaceutical (CHGCY)
is a Sell
Is Chugai Pharmaceutical a Buy, Sell or Hold?
-
The current Chugai Pharmaceutical [CHGCY] share price is $21.34. The Score for CHGCY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
CHGCY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
-
The current Nxera Pharma [SOLTF] share price is $6.16. The Score for SOLTF is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
SOLTF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
CHGCY Stock Price Chart
What is Chugai Pharmaceutical's stock price today?
-
The Chugai Pharmaceutical share price today is $21.34Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHGCY is experiencing slight buying pressure.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $6.16Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOLTF is experiencing slight buying pressure.
CHGCY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 42.46 | Sell |
Chaikin Money Flow: | 22717 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.97 - 22.45) | Sell |
Bollinger Bands (100): | (21.71 - 24.33) | Sell |
SOLTF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.36 | Sell |
Relative Strength Index (14 RSI): | 9.27 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.92 - 8.02) | Sell |
Bollinger Bands (100): | (7.42 - 9.5) | Sell |
CHGCY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.84 | Sell |
20-day SMA: | 21.85 | Sell |
50-day SMA: | 22.7 | Sell |
200-day SMA: | 20.29 | Buy |
8-day EMA: | 21.76 | Sell |
20-day EMA: | 21.97 | Sell |
50-day EMA: | 22.37 | Sell |
200-day EMA: | 20.84 | Buy |
SOLTF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.78 | Sell |
20-day SMA: | 7.32 | Sell |
50-day SMA: | 7.63 | Sell |
200-day SMA: | 9.21 | Sell |
8-day EMA: | 6.77 | Sell |
20-day EMA: | 7.17 | Sell |
50-day EMA: | 7.68 | Sell |
200-day EMA: | 9.01 | Sell |
Chugai Pharmaceutical Earnings Growth & CHGCY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Chugai Pharmaceutical Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nxera Pharma Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |